Wednesday, March 18, 2020 | 12:00 pm – 12:45 pm ET
In response to the Novel Coronavirus (COVID-19) outbreak, China regulatory agencies issued over 70 Emergency Approvals of medical devices, including diagnostic devices, protective supplies and sterilization tools.
As the crisis continues, Emergency Approval pathways remain available for urgently needed products. Unapproved products are imported under emergency situations into China. And this incident holds lessons for all manufacturers considering fast-track options for medical device and IVD registration.
The webinar explains the related guidelines, urgent importations, and how they work in practice, so you can see how they could benefit you to get your products in China faster.
China Med Device has produced the 2020 China NMPA Blue Book: Revised Medical Device and IVD Regulations. This all-in-one resource for medical devices and IVDs provides an up-to-date overview and information on dozens of new regulations, along with clear explanations of how they could affect registration, renewal and post-market compliance for your product in China.
Get your free copy today!
During this informative webinar, you’ll:
- Find out the products that have got NMPA latest emergency approval due to COVID-19;
- Familiarize yourself with key pathways, requirements and relevant regulations for fast track approval in China;
- Discover the urgently needed products;
- Understand the key implications to your China entry strategy moving forward.